Login

Aline Clavert

ORCID: 0000-0003-1270-848X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5062548322
Research Areas
  • Thermal Regulation in Medicine
  • Hematological disorders and diagnostics
  • Respiratory Support and Mechanisms
  • Pediatric Pain Management Techniques

Centre Hospitalier Universitaire d'Angers
 2023

 A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study
OPENALEX - Publications 
Katell Le Dû Anne-Lise Septans Frédéric Maloisel H. Vanquaethem Anna Schmitt and 7 more Marielle Le Goff Aline Clavert Marie Zinger Hugues Bourgeois Olivier Dupuis Fabrice Denis Stéphane Bouchard

Evidence regarding the analgesic effect of distraction through immersion in virtual reality (VR) for care-induced pain has been documented several phase 2 trials, but comparison with standard treatments large, randomized studies is needed.In this open-label, multicenter, randomized, 3 trial, we evaluated safety and efficacy a novel VR therapy solution context bone marrow biopsy.Bliss software 4 imaginary interactive environments dimensions binaural sound (head-mounted display). Efficacy...

10.2196/38619 article EN cc-by Journal of Medical Internet Research 2023-01-09
 A new option in pain prevention with a therapeutic virtual reality solution in bone marrow biopsy context: results of an open-label randomized multicenter phase III study (REVEH Trial) (Preprint)
OPENALEX - Publications 
Katell Le Dû Anne-Lise Septans Frédéric Maloisel H. Vanquaethem Ana Schmitt and 7 more Marielle Le Goff Aline Clavert Marie Zinger Hugues Bourgeois Olivier Dupuis Fabrice Denis Stéphane Bouchard

<sec> <title>BACKGROUND</title> Evidence regarding the analgesic effect of distraction through immersion in virtual reality (VR) for care-induced pain, has been documented several phase II trials but comparison with standard treatments large-randomized studies are needed. </sec> <title>OBJECTIVE</title> In this open-label multicenter randomized III trial (ClinicalTrials.gov identifier: NCT 03483194), we evaluated safety and efficacy a novel VR therapy solution context bone marrow (BM)...

10.2196/preprints.38619 preprint EN 2022-04-09
Coming Soon ...